Alpha interferon as an immunomodulator in the treatment of patients with tumors.
Alvarez-Mon
M
M
Department of Medicine, Hospital Universitario Principe de Asturias, Hospital Universitario General de Guadalajara, Universidad de Alcala de Henares, Spain.
Salmerón
O J
OJ
Manzano
L
L
Rodríguez-Zapata
M
M
Reyes
E
E
Vaquer
L M
LM
Carballido
J
J
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents / Q000145:classification / Q000378:metabolism / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000145:classification / Q000378:metabolism / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D016898:Interferon-alpha